Comparison of Breast Cancer-related Lymphedema (upper Limb Swelling) Prevalence Estimated Using Objective and Subjective Criteria and Relationship with Quality of Life

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Jul 16

PMID 23853774

Citations 20

Authors

Catherine Bulley

Susanne Gaal

Fiona Coutts

Christine Blyth

Wilma Jack

Udi Chetty

Matthew Barber

Chee-Wee Tan

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate lymphedema prevalence using three different measurement/diagnostic criterion combinations and explore the relationship between lymphedema and quality of life for each, to provide evaluation of rehabilitation. Cross-sectional data from 617 women attending review appointments after completing surgery, chemotherapy, and radiotherapy included the Morbidity Screening Tool (MST; criterion: yes to lymphedema); Lymphedema and Breast Cancer Questionnaire (LBCQ; criterion: yes to heaviness and/or swelling); percentage limb volume difference (perometer: %LVD; criterion: 10%+ difference); and the Functional Assessment of Cancer Therapy breast cancer-specific quality of life tool (FACT B+4). Perometry measurements were conducted in a clinic room. Between 341 and 577 participants provided sufficient data for each analysis, with mean age varying from 60 to 62 (SD 9.95-10.03) and median months after treatment from 49 to 51. Lymphedema prevalence varied from 26.2% for perometry %LVD to 20.5% for the MST and 23.9% for the LBCQ; differences were not significant. Limits of agreement analysis between %LVD and the subjective measures showed little consistency, while moderate consistency resulted between the subjective measures. Quality of life differed significantly for women with and without lymphedema only when subjective measurements were used. Results suggest that subjective and objective tools investigate different aspects of lymphedema.

Citing Articles

Vascularized lymph node transfer (VLNT) versus lymphaticovenous anastomosis (LVA) for chronic breast cancer-related lymphedema (BCRL): a retrospective cohort study of effectiveness over time.

Kappos E, Fabi A, Halbeisen F, Abu-Ghazaleh A, Stoffel J, Aufmesser-Freyhardt B Breast Cancer Res Treat. 2024; .

PMID: 39653884 DOI: 10.1007/s10549-024-07567-5.

Quality of Life in Lymphedema Patients Treated by Microsurgical Lymphatic Vessel Transplantation-A Long-Term Follow-Up.

Hock L, Nurnberger T, Koban K, Wiggenhauser P, Giunta R, Demmer W Life (Basel). 2024; 14(8).

PMID: 39202699 PMC: 11355233. DOI: 10.3390/life14080957.

Comprehensive strategies in breast cancer-related lymphedema prevention: insights from a multifaceted program.

Bhimani F, McEvoy M, Chen Y, Gupta A, Pastoriza J, Cavalli A Front Oncol. 2024; 14:1418610.

PMID: 39081716 PMC: 11286467. DOI: 10.3389/fonc.2024.1418610.

Technical aspects and validation of custom digital algorithms for hand volumetry.

Nascimben M, Lippi L, Fusco N, de Sire A, Invernizzi M, Rimondini L Technol Health Care. 2023; 31(5):1835-1854.

PMID: 37302048 PMC: 10578236. DOI: 10.3233/THC-220694.

The Impact of Lymphedema on Patient-Reported Outcomes After Breast Reconstruction: A Preliminary Propensity Score-Matched Analysis.

Coriddi M, Kim L, Haglich K, McGrath L, Monge J, Shamsunder M Ann Surg Oncol. 2023; 30(5):3061-3071.

PMID: 36641512 PMC: 11071662. DOI: 10.1245/s10434-022-12994-z.

References

Lee T, Kilbreath S, Refshauge K, Herbert R, Beith J . Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat. 2007; 110(1):19-37. DOI: 10.1007/s10549-007-9710-9. View

Altman D, Bland J . Diagnostic tests. 1: Sensitivity and specificity. BMJ. 1994; 308(6943):1552. PMC: 2540489. DOI: 10.1136/bmj.308.6943.1552. View

Armer J, Fu M . Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs. 2005; 28(3):200-7. DOI: 10.1097/00002820-200505000-00007. View

Gartner R, Jensen M, Kronborg L, Ewertz M, Kehlet H, Kroman N . Self-reported arm-lymphedema and functional impairment after breast cancer treatment--a nationwide study of prevalence and associated factors. Breast. 2010; 19(6):506-15. DOI: 10.1016/j.breast.2010.05.015. View

Mak S, Mo K, Suen J, Chan S, Ma W, Yeo W . Lymphedema and quality of life in Chinese women after treatment for breast cancer. Eur J Oncol Nurs. 2009; 13(2):110-5. DOI: 10.1016/j.ejon.2009.01.005. View

Sander A, Hajer N, Hemenway K, Miller A . Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther. 2002; 82(12):1201-12. View

Velanovich V, Szymanski W . Quality of life of breast cancer patients with lymphedema. Am J Surg. 1999; 177(3):184-7; discussion 188. DOI: 10.1016/s0002-9610(99)00008-2. View

. The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology. 2003; 36(2):84-91. View

Querci Della Rovere G, Ahmad I, Singh P, Ashley S, Daniels I, Mortimer P . An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl. 2003; 85(3):158-61. PMC: 1964383. DOI: 10.1308/003588403321661299. View

10.

Deltombe T, Jamart J, Recloux S, LeGrand C, Vandenbroeck N, Theys S . Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema. Lymphology. 2007; 40(1):26-34. View

11.

Hayes S, Cornish B, Newman B . Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat. 2005; 89(3):221-6. DOI: 10.1007/s10549-004-2045-x. View

12.

Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S . Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol. 1997; 15(3):974-86. DOI: 10.1200/JCO.1997.15.3.974. View

13.

Morgan P, Franks P, Moffatt C . Health-related quality of life with lymphoedema: a review of the literature. Int Wound J. 2006; 2(1):47-62. PMC: 7951421. DOI: 10.1111/j.1742-4801.2005.00066.x. View

14.

Armer J, Stewart B, Shook R . 30-MONTH POST-BREAST CANCER TREATMENT LYMPHOEDEMA. J Lymphoedema. 2010; 4(1):14-18. PMC: 2826842. View

15.

Karges J, Mark B, Stikeleather S, Worrell T . Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther. 2003; 83(2):134-45. View

16.

Bland K, Perczyk R, Du W, Rymal C, Koppolu P, McCrary R . Can a practicing surgeon detect early lymphedema reliably?. Am J Surg. 2003; 186(5):509-13. DOI: 10.1016/j.amjsurg.2003.07.003. View

17.

Truong P, Olivotto I, Whelan T, Levine M . Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ. 2004; 170(8):1263-73. PMC: 385392. DOI: 10.1503/cmaj.1031000. View

18.

Armer J, Radina M, Porock D, Culbertson S . Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003; 52(6):370-9. DOI: 10.1097/00006199-200311000-00004. View

19.

Thomas-Maclean R, Hack T, Kwan W, Towers A, Miedema B, Tilley A . Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008; 35(1):65-71. DOI: 10.1188/08.ONF.65-71. View

20.

Coster S, Poole K, Fallowfield L . The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat. 2001; 68(3):273-82. DOI: 10.1023/a:1012278023233. View